Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

Brooklyn Clinical Research10,000 enrolled

Overview

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.

Study Type

OBSERVATIONAL

Enrollment

10,000

Conditions

Cardiovascular Diseases Obesity PreDiabetes Diabetes Type 2 Metabolic Syndrome

Interventions

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed. 2. Participant is at least 18 years old. Exclusion Criteria: 1. Participant is pregnant, breast-feeding, or planning to become pregnant. 2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. 3. Moderate or severe substance use disorder within 90 days prior to screen 4. Any condition that in the investigator's opinion makes a participant unsuitable for the study. 5. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.

Outcomes

Primary Outcomes

Number of participants who are interested in industry-sponsored clinical research

Number of participants who are interested in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, obesity, and endocrine.

Time frame: 5 years

Secondary Outcomes

Characteristics associated with patient populations interested in clinical trials

Characteristics associated with patient populations interested in clinical trials stratified by demographics and therapeutic areas